|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
11655062 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
180521s2018 sz a ob 001 0 eng d |
005 |
20240709185030.4 |
015 |
|
|
|a GBB8K7286
|2 bnb
|
016 |
7 |
|
|a 019109855
|2 Uk
|
019 |
|
|
|a 1037806436
|a 1039400241
|a 1040651185
|a 1042937309
|a 1047675442
|a 1055385320
|a 1058160154
|a 1066607699
|a 1079806120
|a 1086475718
|a 1112866523
|a 1116200265
|a 1122814014
|a 1125704601
|a 1136265843
|a 1160038690
|a 1162754060
|
020 |
|
|
|a 9783319743912
|q (electronic bk.)
|
020 |
|
|
|a 3319743910
|q (electronic bk.)
|
020 |
|
|
|z 9783319743905
|q (print)
|
020 |
|
|
|z 3319743902
|
024 |
7 |
|
|a 10.1007/978-3-319-74391-2
|2 doi
|
035 |
|
|
|a (OCoLC)1037001048
|z (OCoLC)1037806436
|z (OCoLC)1039400241
|z (OCoLC)1040651185
|z (OCoLC)1042937309
|z (OCoLC)1047675442
|z (OCoLC)1055385320
|z (OCoLC)1058160154
|z (OCoLC)1066607699
|z (OCoLC)1079806120
|z (OCoLC)1086475718
|z (OCoLC)1112866523
|z (OCoLC)1116200265
|z (OCoLC)1122814014
|z (OCoLC)1125704601
|z (OCoLC)1136265843
|z (OCoLC)1160038690
|z (OCoLC)1162754060
|
035 |
|
9 |
|a (OCLCCM-CC)1037001048
|
037 |
|
|
|a com.springer.onix.9783319743912
|b Springer Nature
|
040 |
|
|
|a GW5XE
|b eng
|e rda
|e pn
|c GW5XE
|d EBLCP
|d N$T
|d YDX
|d AZU
|d UAB
|d OCLCF
|d OCLCQ
|d UPM
|d MERER
|d VT2
|d OCLCQ
|d U3W
|d AU@
|d CNCEN
|d WYU
|d OCLCQ
|d LVT
|d UKMGB
|d DKU
|d CAUOI
|d LEAUB
|d OCLCQ
|d ADU
|d LEATE
|d UKAHL
|d OCLCQ
|d SFB
|d OCLCQ
|
049 |
|
|
|a MAIN
|
050 |
|
4 |
|a HV6545
|
072 |
|
7 |
|a POL
|x 027000
|2 bisacsh
|
072 |
|
7 |
|a POL
|x 019000
|2 bisacsh
|
072 |
|
7 |
|a MMH
|2 bicssc
|
072 |
|
7 |
|a MKL
|2 thema
|
245 |
0 |
0 |
|a Suicide prevention :
|b a practical guide for the practitioner /
|c Tatiana Falcone, Jane Timmons-Mitchell, editors.
|
264 |
|
1 |
|a Cham, Switzerland :
|b Springer,
|c 2018.
|
300 |
|
|
|a 1 online resource (xvi, 311 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed May 21, 2018).
|
505 |
0 |
|
|a Intro; Acknowledgments; Contents; Contributors; Introduction; Part I: Introduction; 1: Neurobiology of Suicide; Introduction; Epidemiology; Clinical Predictors of Suicidality; Neurobiology; Biomarkers of Suicidality; Serotonin; Noradrenergic System and Suicide; Dopamine; Acetylcholine; Neurotrophins and BDNF; Neuroinflammatory Markers of Suicidality: Evidence of Increased Inflammation in Patients After a Suicide Attempt?; Individual Inflammatory Markers; Cytokines; IL1-B; IL-2; IL-6; TNF-Alpha; IFN-Gamma; C-Reactive Protein; Kynurenic/Quinolinic Acid; S100B.
|
505 |
8 |
|
|a S100B levels ng/mL by BPRS Suicidality Score (Fig. 1.1)Brain-Derived Neurotrophic Factor (BDNF); Vascular Endothelial Growth Factor (VEGF); Orexin; Autoimmunity and Suicide; Infections: Toxoplasma gondii; References; 2: Mood Disorders and Suicide; Introduction; Epidemiology; Etiological Theories; Biological Factors; Psychological Factors; Social/Environmental Factors; Risk Factors; Risk Assessment; Management; Prevention and Treatment; References; 3: Psychosis and Suicide; Overview; Suicide and Schizophrenia; Suicide and First-Episode Psychosis; Risk Factors; Protective Factors; Assessment.
|
505 |
8 |
|
|a Screening MeasuresAssessment Measures; Treatment; Early Intervention; Cognitive Behavioral Therapy; Multisystemic Therapy-Psychiatric; Medications; References; Part II: Special Populations; 4: Suicide in Children; Introduction; Terminology; Epidemiology; Youth Ages 5-11 Years; Youth Ages 10-14 Years; Youth Ages 15-19 Years; Youth Ages 19-24 Years; Risk Factors; Psychopathology; Depression; Previous Suicidal Behavior; Substance Abuse; Family Factors; Familial Transmission of Suicidal Behaviors; Childhood Trauma; Sexual Orientation and Gender Identity; Sexual Orientation; Gender Identity.
|
505 |
8 |
|
|a BullyingAcademic Pressure; Autism Spectrum Disorder (ASD) and/or Intellectual Disabilities (ID); Medical Illness; Implication of Assessment and Management by Risk Factor; Protective Factors; Social Connectedness; Internal Locus of Control; Effective Coping Strategies; Religiosity; Importance of Screening as Means of Prevention; Cultural Considerations; Assessment; Patient Physical Examination; Physical Exam; Laboratory Evaluation; Management; Treatments; Selective Serotonin Reuptake Inhibitors (SSRIs) and Suicidality; Make a Safety Plan with the Patient.
|
505 |
8 |
|
|a Ability to Consent/Legal/ConfidentialityDocumentation; Resources; References; 5: Substance Abuse and Suicide; Introduction; Alcohol Use and Suicide; Opioid Use and Suicide; Cocaine Use and Suicide; References; 6: Suicide in Children and Adults with Epilepsy: A Complex Relationship; Introduction; Prevalence Rates of Suicide and Suicidal Behavior in Epilepsy; Suicide in Adults with Epilepsy; Prevalence Rates of Suicidal Ideation and Suicidal Attempts in Adults with Epilepsy; Prevalence Rates of Suicide, Suicide Attempts, and Suicidal Ideation in Youth with Epilepsy.
|
520 |
|
|
|a The book begins by establishing the neurobiology of suicide before discussing the populations at risk for suicide and the various environments where they may present. The book addresses the epidemiology, including groups at heightened risk; etiology, including several types of risk factors; prevention, including large-scale community-based activities; and postvention, including the few evidence-based approaches that are currently available. Unlike any other text on the market, this book does not simply focus on one particular demographic; rather, the book covers a wide range of populations and concerns, including suicide in youths, racial minorities, patients suffering from serious mental and physical illnesses, psychopharmacological treatment in special populations, and a wide array of challenging scenarios that are often not addressed in the very few up-to-date resources available. Suicide Prevention is an outstanding resource for psychiatrists, psychologists, hospitalists, primary care doctors, nurses, social workers, and all medical professionals who may interface with suicidal patients.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Suicide
|x Prevention.
|0 http://id.loc.gov/authorities/subjects/sh85129743
|
650 |
|
0 |
|a Suicidal behavior
|x Treatment.
|
650 |
|
7 |
|a General practice.
|2 bicssc
|
650 |
|
7 |
|a Public health & preventive medicine.
|2 bicssc
|
650 |
|
7 |
|a Accident & emergency medicine.
|2 bicssc
|
650 |
|
7 |
|a Nursing.
|2 bicssc
|
650 |
|
7 |
|a Psychiatry.
|2 bicssc
|
650 |
|
7 |
|a POLITICAL SCIENCE
|x Public Policy
|x Social Security.
|2 bisacsh
|
650 |
|
7 |
|a POLITICAL SCIENCE
|x Public Policy
|x Social Services & Welfare.
|2 bisacsh
|
650 |
|
7 |
|a Suicidal behavior
|x Treatment.
|2 fast
|0 (OCoLC)fst01137577
|
650 |
|
7 |
|a Suicide
|x Prevention.
|2 fast
|0 (OCoLC)fst01137587
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Falcone, Tatiana,
|e editor.
|
700 |
1 |
|
|a Timmons-Mitchell, Jane,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Suicide prevention.
|d Cham, Switzerland : Springer, 2018
|z 3319743902
|z 9783319743905
|w (OCoLC)1016050682
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a oclccm
|
999 |
f |
f |
|i ade2fc38-ff0f-5d3d-9db1-f8c84ed5ff61
|s 01890d55-78f6-54dc-9e51-ab57b0f92465
|
928 |
|
|
|t Library of Congress classification
|a HV6545
|l Online
|c UC-FullText
|u https://link.springer.com/10.1007/978-3-319-74391-2
|z Springer Nature
|g ebooks
|i 12554209
|